140 related articles for article (PubMed ID: 22208613)
1. Genomic sequencing of key genes in mouse pancreatic cancer cells.
Wang Y; Zhang Y; Yang J; Ni X; Liu S; Li Z; Hodges SE; Fisher WE; Brunicardi FC; Gibbs RA; Gingras MC; Li M
Curr Mol Med; 2012 Mar; 12(3):331-41. PubMed ID: 22208613
[TBL] [Abstract][Full Text] [Related]
2. The Mutation Portraits of Oncogenes and Tumor Supressor Genes in Predicting the Overall Survival in Pancreatic Cancer: A Bayesian Network Meta-Analysis.
Aryanti C; Uwuratuw JA; Labeda I; Raharjo W; Lusikooy RE; Rauf MA; Mappincara A; Sampetoding S; Kusuma MI; Syarifuddin E
Asian Pac J Cancer Prev; 2023 Aug; 24(8):2895-2902. PubMed ID: 37642079
[TBL] [Abstract][Full Text] [Related]
3. Prediction of survival and recurrence in patients with pancreatic cancer by integrating multi-omics data.
Baek B; Lee H
Sci Rep; 2020 Nov; 10(1):18951. PubMed ID: 33144687
[TBL] [Abstract][Full Text] [Related]
4. The targeted next-generation sequence revealed SMAD4, AKT1, and TP53 mutations from circulating cell-free DNA of breast cancer and its effect on protein structure - A computational approach.
Balasundaram A; Kumar S U; D TK; Anil Dedge A; R G; K SS; R S; C GPD
J Biomol Struct Dyn; 2023; 41(24):15584-15597. PubMed ID: 37011004
[TBL] [Abstract][Full Text] [Related]
5. Selective epigenetic alterations in RNF43 in pancreatic exocrine cells from high-fat-diet-induced obese mice; implications for pancreatic cancer.
Araki T; Miwa N
BMC Res Notes; 2024 Apr; 17(1):106. PubMed ID: 38622664
[TBL] [Abstract][Full Text] [Related]
6. Generation and molecular characterization of pancreatic cancer patient-derived xenografts reveals their heterologous nature.
Jung J; Lee CH; Seol HS; Choi YS; Kim E; Lee EJ; Rhee JK; Singh SR; Jun ES; Han B; Hong SM; Kim SC; Chang S
Oncotarget; 2016 Sep; 7(38):62533-62546. PubMed ID: 27613834
[TBL] [Abstract][Full Text] [Related]
7. Significance of TP53, CDKN2A, SMAD4 and KRAS in Pancreatic Cancer.
Stefanoudakis D; Frountzas M; Schizas D; Michalopoulos NV; Drakaki A; Toutouzas KG
Curr Issues Mol Biol; 2024 Mar; 46(4):2827-2844. PubMed ID: 38666907
[TBL] [Abstract][Full Text] [Related]
8. Hierarchical molecular tagging to resolve long continuous sequences by massively parallel sequencing.
Lundin S; Gruselius J; Nystedt B; Lexow P; Käller M; Lundeberg J
Sci Rep; 2013; 3():1186. PubMed ID: 23470464
[TBL] [Abstract][Full Text] [Related]
9. IVT generation of guideRNAs for Cas9-enrichment Nanopore Sequencing.
Gilpatrick T; Wang JZ; Weiss D; Norris AL; Eshleman J; Timp W
bioRxiv; 2023 Feb; ():. PubMed ID: 36798399
[TBL] [Abstract][Full Text] [Related]
10. Molecular pathways in periampullary cancer: An overview.
Apurva ; Abdul Sattar RS; Ali A; Nimisha ; Kumar Sharma A; Kumar A; Santoshi S; Saluja SS
Cell Signal; 2022 Dec; 100():110461. PubMed ID: 36096460
[TBL] [Abstract][Full Text] [Related]
11. A new intronic quantitative PCR method led to the discovery of transformation from human ascites to murine malignancy in a mouse model.
Jin J; Huo L; Fan Y; Wang R; Scott AW; Pizzi MP; Yao X; Shao S; Ma L; Da Silva MS; Yamashita K; Yoshimura K; Zhang B; Wu J; Wang L; Song S; Ajani JA
Front Oncol; 2023; 13():1062424. PubMed ID: 36865791
[TBL] [Abstract][Full Text] [Related]
12. Induction and chemotherapeutic response of two transplantable ductal adenocarcinomas of the pancreas in C57BL/6 mice.
Corbett TH; Roberts BJ; Leopold WR; Peckham JC; Wilkoff LJ; Griswold DP; Schabel FM
Cancer Res; 1984 Feb; 44(2):717-26. PubMed ID: 6692374
[TBL] [Abstract][Full Text] [Related]
13. Novel pancreatic cancer cell lines derived from genetically engineered mouse models of spontaneous pancreatic adenocarcinoma: applications in diagnosis and therapy.
Torres MP; Rachagani S; Souchek JJ; Mallya K; Johansson SL; Batra SK
PLoS One; 2013; 8(11):e80580. PubMed ID: 24278292
[TBL] [Abstract][Full Text] [Related]
14. Establishment of an orthotopic pancreatic cancer mouse model: cells suspended and injected in Matrigel.
Jiang YJ; Lee CL; Wang Q; Zhou ZW; Yang F; Jin C; Fu DL
World J Gastroenterol; 2014 Jul; 20(28):9476-85. PubMed ID: 25071342
[TBL] [Abstract][Full Text] [Related]
15. Targeted depletion of an MDSC subset unmasks pancreatic ductal adenocarcinoma to adaptive immunity.
Stromnes IM; Brockenbrough JS; Izeradjene K; Carlson MA; Cuevas C; Simmons RM; Greenberg PD; Hingorani SR
Gut; 2014 Nov; 63(11):1769-81. PubMed ID: 24555999
[TBL] [Abstract][Full Text] [Related]
16. Comparison of two syngeneic orthotopic murine models of pancreatic adenocarcinoma.
Nikfarjam M; Yeo D; He H; Baldwin G; Fifis T; Costa P; Tan B; Yang E; Wen Sw; Christophi C
J Invest Surg; 2013 Dec; 26(6):352-9. PubMed ID: 23957638
[TBL] [Abstract][Full Text] [Related]
17. Identification of tumorigenic and therapeutically actionable mutations in transplantable mouse tumor cells by exome sequencing.
Bhadury J; López MD; Muralidharan SV; Nilsson LM; Nilsson JA
Oncogenesis; 2013 Apr; 2(4):e44. PubMed ID: 23588493
[TBL] [Abstract][Full Text] [Related]
18. Development of orthotopic pancreatic tumor mouse models.
Qiu W; Su GH
Methods Mol Biol; 2013; 980():215-23. PubMed ID: 23359156
[TBL] [Abstract][Full Text] [Related]
19. A preclinical murine model of hepatic metastases.
Soares KC; Foley K; Olino K; Leubner A; Mayo SC; Jain A; Jaffee E; Schulick RD; Yoshimura K; Edil B; Zheng L
J Vis Exp; 2014 Sep; (91):51677. PubMed ID: 25285458
[TBL] [Abstract][Full Text] [Related]
20. IL-6 and PD-L1 antibody blockade combination therapy reduces tumour progression in murine models of pancreatic cancer.
Mace TA; Shakya R; Pitarresi JR; Swanson B; McQuinn CW; Loftus S; Nordquist E; Cruz-Monserrate Z; Yu L; Young G; Zhong X; Zimmers TA; Ostrowski MC; Ludwig T; Bloomston M; Bekaii-Saab T; Lesinski GB
Gut; 2018 Feb; 67(2):320-332. PubMed ID: 27797936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
